The Evaluation of Left Ventricular Function for Patients Being Considered For, or Receiving Trastuzumab (Herceptin) Therapy

British Journal of Cancer- United Kingdom

doi 10.1038/sj.bjc.6603340

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search